Bone Neoplasms

4

Review clinical trials related to Bone Neoplasms. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Neoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma

This is a single-center, single-arm, prospective observational study to evaluate the long-term local control rate, safety, and efficacy of preoperative neoadjuvant radiotherapy (36-45 Gy) followed by sequential radical surgery and postoperative chemotherapy in patients with high-risk, resectable localized Ewing sarcoma.

Participants needed: 55
Trial details
Age: 12+Biological sex: AllType: ObservationalSponsor: Peking University People's HospitalUpdated: Jun 2, 2026Locations: 1
Eligibility criteria

The subject or their legal representative signs the written informed consent pri... [+6]

No opportunity for surgical resection after neoadjuvant chemotherapy. [+6]

Status: Recruiting

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the case of rare diseases, such as bone and soft tissue tumors. It is therefore the purpose of this study to create a prospective EHR-based clinical registry for individuals with bone and soft-tissue tumors.

Participants needed: 1,500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Ohio State University Comprehensive Cancer CenterUpdated: Feb 11, 2026Locations: 1Duration: 5 Years
Eligibility criteria

Must have a diagnosis or presumed diagnosis of bone or soft tissue tumor as defi... [+1]

Prisoners are excluded from participation in the Registry.

Status: Recruiting

Radiotherapy Treatments for Neoplasms of the Limbs

In this observational study patients treated at European Institute of Oncology with radiotherapy to limbs will be included

Participants needed: 3,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: European Institute of OncologyUpdated: Aug 28, 2025Locations: 1
Eligibility criteria

Signed informed consent

Status: Not yet recruiting

Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors

Investigate the application protocol, feasibility, and efficacy of indocyanine green (ICG)-assisted near-infrared (NIR) fluorescence-guided resection in bone and soft tissue tumors. Assess the incidence of adverse events and evaluate the safety of the protocol.

Participants needed: 40
Trial details
Biological sex: AllType: ObservationalSponsor: Guangdong Provincial People's HospitalUpdated: May 18, 2025Locations: 1
Eligibility criteria

Histologically confirmed diagnosis of bone and soft tissue tumors (according to... [+2]

Presence of severe or chronic kidney, liver, or pulmonary diseases. [+2]